MOLECULAR CELL BIOLOGY OF AMYLOID PRECURSOR PROTEIN
MOLECULAR CELL BIOLOGY OF AMYLOID PRECURSOR PROTEIN
批准号:
2050740
负责人:
WILLIAM L KLEIN
金额:
$14.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-01 至 1995-04-30
关键词:
Alzheimer's disease aluminum amyloid proteins antibody axon calcium cell adhesion cell adhesion molecules cell death cell membrane cytoskeleton dendrites electron microscopy glucose growth cones heat stimulus hypoxia laboratory rabbit molecular biology neurogenesis neurons oxidation physiologic stressor protein purification protein structure protein structure function receptor stress stress proteins tissue /cell culture transmission electron microscopy
中文摘要
这项工作的长期目标涉及细胞的分子机制,
阿尔茨海默病(AD)的死亡。 其直接重点是研究
淀粉样前体蛋白(APP)的分子细胞生物学。 的
APP在原位的细胞结构性质,其功能作用,以及
影响其表达的因素基本上是未知的。 拟议
这些目标旨在解决这些差距,此外,还将有助于建立一个
为AD神经发病机制的实验研究提供了新的模型。
目的#1-表征APP在细胞中的结构生物学,
细胞外表面,侧重于测试的假设,APP可能
是细胞粘附分子。 虽然APP的细胞功能是
未知,基于序列分析的一个主要假设是,
蛋白质是细胞粘附分子。 为了直接验证这个假设,
并原位表征APP分子的结构生物学,
我们最近开发了一种整装EM免疫金方法,
研究APP在培养的人类神经细胞系中的表达。 基于我们
试点研究,我们建议(1)为了验证和扩展表征
APP形式和粘附性微纤维之间的关系,
细胞和细胞外表面,应用整体安装传输
SHSY 5 Y人神经母细胞瘤的电镜-免疫金方法
细胞培养(2)为了评价APP的粘附作用,使用范例
测试神经突起的延伸和生长等与粘连相关的功能
视锥运动(3)提供假设的APP的初始表征
受体,使用基于粘附特性的分离方案,
附录
目的#2-评估细胞应激因素对
APP表达。 已知APP启动子具有多重控制作用,
元素,包括应力相关的热休克序列。 实验
因此,我们设计了研究APP表达的方法,
外部影响会给神经细胞带来压力。 六个因素
直接或间接参与AD的发病机制,
研究(热休克、Ca++过载、葡萄糖戒断、缺氧、氧化剂
铝(铝)。 APP在细胞上的分布
和培养表面将使用成像技术进行比较;
与细胞和培养基质相关的APP形式的水平将被
通过定量免疫印迹测定。 这些数据将提供重要的
细胞应激引起显著变化的假设的检验,或
APP表达异常。
英文摘要
The long-range goal of this work concerns molecular mechanisms of cell
death in Alzheimer's disease (AD). Its immediate focus is to study the
molecular cell biology of amyloid precursor protein (APP). The
cytoarchitectural nature of APP in situ, its functional role, and the
factors influencing its expression are essentially unknown. The proposed
aims address these gaps and, additionally, will help to establish a
useful new model for experimental studies of AD neuropathogenesis.
AIM #1- To characterize the structural biology of APP at cell and
extracellular surfaces, focusing on tests of the hypothesis that APP may
be a cell adhesion molecule. While the cellular function of APP is
unknown, one major hypothesis based on sequence analysis is that this
protein is a cell adhesion molecule. To test this hypothesis directly,
and to characterize the structural biology of the APP molecule in situ,
we recently have developed a whole mount EM-immunogold method for
studying APP expression in cultured human nerve cell lines. Based on our
pilot studies, we propose (1) To verify and extend characterization of
the relationship between APP forms and adhesive microfibrils found at
cell and extracellular surfaces, applying whole mount transmission
electron microscopy-immunogold protocols to SHSY5Y human neuroblastoma
cell cultures. (2) To evaluate the adhesive role of APP, using paradigms
that test adhesion-linked functions such as neurite extension and growth
cone motility (3) To provide initial characterization of a postulated APP
receptor, using isolation protocols based on the adhesive properties of
APP.
AIM #2- To evaluate the influence of cellular stress factors on
APP expression. The APP promoter is known to have multiple control
elements, including a stress-related heat shock sequence. Experiments
therefore have been designed to study APP expression in response to
external influences that can stress nerve cells. Six factors
incriminated directly or indirectly in the pathogenesis of AD will be
studied (heat shock, Ca++ overload, glucose withdrawal, hypoxia, oxidant
injury, and aluminum). The distribution of specific APP forms on cell
and culture surfaces will be compared using imaging techniques; the
levels of APP forms associated with cells and culture substratum will be
measured by quantitative immunoblots. The data will provide essential
tests of the hypothesis that cell stress causes significant changes or
anomalies in APP expression.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Physiological role of naturally-occuring amyloid beta oligomers
-
批准号:9759747
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2018
-
负责人:WILLIAM L KLEIN
-
依托单位:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
-
批准号:9202960
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2016
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8842908
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8683797
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8548221
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8446087
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7615522
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7184209
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7470605
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
-
批准号:6678227
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7805554
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6931646
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7467169
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6795925
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7595791
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6233462
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6615732
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6532552
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2703069
-
项目类别:
-
资助金额:$19.22万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2273680
-
项目类别:
-
资助金额:$18.86万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
国内基金
海外基金
Aluminum/CFRP 混合管界面分层对渐进折叠机制影响研究
-
批准号:ZCLQN26E0501
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:沈勇
-
依托单位: